Epstein-Barr virus infection in sixty pediatric liver graft recipients: Diagnosis of primary infection and virologic follow-up

Pediatric Infectious Disease Journal

Volumn 18, Issue 8, 1999, Pages 698-702

  Bodéus, Monique ^a   Smets, Françoise ^a   Reding, Raymond ^a   Sokal, Etienne ^a   Otte, Jean Bernard ^a   Goubau, Patrick ^a   Van Renterghem, Lieve ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Epstein Bart virus; Liver transplantation; Polymerase chain reaction; Serology

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; SCHOOL CHILD; VIRUS DETECTION; VIRUS INFECTION;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; INFECTIOUS MONONUCLEOSIS; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION;

EID: 0344562882     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199908000-00009     Document Type: Article

References (29)

1. Breinig MK, Zitelli B, Starzl T, Ho M. Epstein-Barr virus, cytomegalovirus and other viral infections in children after liver transplantation. J Infect Dis 1987;156:273-9.
2. Cames B, Rahier J, Burtonboy G, et al. Acute adenovirus hepatitis in liver transplant recipients. J Pediatr 1992;120: 33-7.
3. Salt A, Sutehall G, Sargaison M, et al. Viral and Toxoplasma gondii infections in children after liver transplantation. J Clin Pathol 1990;43:63-7.
4. Green M, Tzakis A, Reyes J, Nour B, Todo S, Starzl TE. Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991;23:3038-9.
5. Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation: interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 1996;62:370-5.
6. Reding R, Wallemacq PE, Lamy ME, et al. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allograft. Transplantation 1994;57:93-100.
7. Swinnen LJ, Costanzo Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990;323:1723-8.
8. Malatack JF, Gartner JC, Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine and lymphoproliferative disease: a growing concern. J Pediatr 1991;11:667-75.
9. Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV seroconversion and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991;23:1473-6.
10. Boyle GJ, Michaels MG, Webber SA, et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr 1997;131:309-13.
11. Nalesnik MA. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg 1996;8:139-48.
12. Randhawa P, Jaffe R, Demetris A, et al. Expression of Epstein-Barr virus encoded small RNA (by the EBER 1 gene) in liver specimens from transplant recipients with posttransplantation lymphoproliferative disease. N Engl J Med 1992;327:1710-14.
13. Sokal EM, Antunes H, Beguin C, et al. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation 1997;64:1438-42.
14. Bodéus M, Feyder S, Goubau P. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diagn Virol 1998;9:9-16.
15. Laroche C, Drouet EB, Brousset P, et al. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas. J Med Virol 1995;46:66-74.
16. Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B. Incidence and consequences of posttransplantation lymphoproliferative disorders. J Nephrol 1997;10:136-45.
17. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Posttransplant lymphoproliferative disorder in renal allograft recipient: clinical experience and risk factor analysis in a single center. Transplantation 1993;56:88-96.
18. Dockrell DH, Strickler JG, Paya CV. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients. Clin Infect Dis 1998;26:180-2.
19. Rosendale B, Yousem SA. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. Arch Pathol Lab Med 1995;119:418-23.
20. Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993;56:1394-8.
21. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy T, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995;59:524-9.
22. Morgan G, Superina RA. Lymphoproliferative diseases after pediatric liver transplantation. J Pediatr Surg 1994;29: 1192-6.
23. Fischer A, Blanche S, Le Bidois J, et al. Anti B cell monoclonal antibodies in the treatment of severe B cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991;324:1451-6.
24. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation 1988;45:719-27.
25. Hanto D, Frizzera G, Kazimiera J, Peczalska G, Simmons R. Epstein-Barr virus, immunodeficiency and B cell lymphoproliferation. Transplantation 1985;39:461-72.
26. Green M, Kaufmann M, Wilson J, Reyes J. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. Clin Infect Dis 1997;25:1344-9.
27. O'Brien S, Bernert RA, Logan JL, Lien YH. Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy. J Am Soc Nephrol 1997;8:1483-9.
28. Savoie A, Perpête CL, Carpentier L, Joncas J, Alfieri C. Direct correlation between the load of EBV-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994;83:2715-22.
29. Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995;60:547-54.